Zhejiang Medicine Co., Ltd. (600216.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 12.55

From 52W high−31.72%

Volume12.18M

Market capCNY 12.07B

P/E (TTM)13.8x

P/S (TTM)1.4x

Div yield2.23%

Key dataSep 18, 2026

Open

CNY 12.55

From 52W high

−31.72%

Volume

12.18M

Market cap

CNY 12.07B

ValuationView details →

P/E (Fwd)

11.6x

EV/EBITDA

5.7x

P/E (TTM)

13.8x

RSI (14)

46.9

MomentumView details →

1D Return

−5.14%

YTD Return

−9.45%

ValuationView details →

P/E (Fwd)

11.6x

P/E (TTM)

13.8x

EV/EBITDA

5.7x

EV/Sales

1.1x

P/S (TTM)

1.4x

P/B (TTM)

1.1x

ProfitabilityView details →

Gross Margin

32.53%

Net Margin

8.52%

EBITDA Margin

19.96%

ROE (TTM)

6.68%

ROA (TTM)

5.30%

Asset Turnover

0.62x

GrowthView details →

Revenue YoY

−6.03%

EPS YoY

−48.61%

FCF YoY

+42.64%

Revenue CAGR 3Y

+3.05%

EPS CAGR 3Y

+17.57%

EBITDA YoY

—

MomentumView details →

1D Return

−5.14%

YTD Return

−9.45%

1Y Return

−13.63%

RSI (14)

46.9

vs 50D SMA

−0.62%

vs 200D SMA

−9.55%

Capital & dividendView details →

Debt/Equity

0.07x

Current Ratio

3.39x

Quick Ratio

2.54x

Div Yield

2.23%

Div Rate

CNY 0.28

Div Growth 1Y

−24.32%

EarningsView details →

EPS (Actual)

CNY 0.25

EPS Surprise

0.00%

Beats (12Q)

0/12

Next Q EPS Est

CNY 0.29

Avg Surprise (4Q)

0.00%

Rev Surprise

0.00%

Financials snapshotView financials →

Revenue (TTM)

8.82B

Net Income (TTM)

751.31M

Op. CF (TTM)

1.68B

Next earningsOct 22, 2026 →

Latest newsMore news →

Zhejiang Medicine and Puhua Capital's affiliate Zhejiang Puhua Tianqin Equity Investment Management jointly established Puhua Fengqi Phase II (Hangzhou) Venture Capital Fund Partnership in Hangzhou with 210 million yuan in capital contributions.6d ago

China's National Healthcare Security Administration held a symposium on August 27, 2026, with 16 pharmaceutical companies to discuss industry development and gather opinions for the 15th Five-Year Plan period.24d ago

Similar companies

国邦医药605507.SH Sunshine Lake Pharma Co., Ltd.06887.HK 健友股份603707.SH Ab&B Bio Tech Co Ltd.02627.HK 微芯生物688321.SH XD国药现600420.SH Find similar companies →

Latest newsMore news →

Zhejiang Medicine and Puhua Capital's affiliate Zhejiang Puhua Tianqin Equity Investment Management jointly established Puhua Fengqi Phase II (Hangzhou) Venture Capital Fund Partnership in Hangzhou with 210 million yuan in capital contributions.6d ago China's National Healthcare Security Administration held a symposium on August 27, 2026, with 16 pharmaceutical companies to discuss industry development and gather opinions for the 15th Five-Year Plan period.24d ago